Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
426
CALL
DELISTED
Endo International plc
ENDP
| $21M | 0.02% |
+300,000
| New | +$20.1M |
|
427
Southern Copper
SCCO
$138B
| $20.8M | 0.02% |
738,260
-29,070
| -4% | -$800K |
|
|
LMOS
428
DELISTED
Lumos Networks Corp
LMOS
| $20.8M | 0.02% |
1,436,127
-729
| -0.1% | -$10K |
|
429
NETSCOUT
NTCT
$2.83B
| $20.2M | 0.02% |
454,534
-1,273
| -0.3% | -$49.4K |
|
430
Tandem Diabetes Care
TNDM
$1.14B
| $19.8M | 0.02% |
121,936
+17,689
| +17% | +$3.01M |
|
431
Prothena Corp
PRTA
$458M
| $19.7M | 0.02% |
874,794
+104,060
| +14% | +$2.6M |
|
|
CSII
432
DELISTED
Cardiovascular Systems, Inc.
CSII
| $19.7M | 0.02% |
631,329
+167,878
| +36% | +$4.84M |
|
433
BOK Financial
BOKF
$8.64B
| $19.7M | 0.02% |
295,350
-24,523
| -8% | -$1.6M |
|
|
PTLA
434
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $18.7M | 0.02% |
641,046
-76,170
| -11% | -$1.84M |
|
435
McEwen Inc
MUX
$1.04B
| $18.3M | 0.02% |
634,551
+22,468
| +4% | +$542K |
|
436
Commault Systems
CVLT
$6.18B
| $18.2M | 0.02% |
371,019
-106,607
| -22% | -$5.74M |
|
437
Avient
AVNT
$3.35B
| $18.2M | 0.02% |
+432,639
| New | +$16.9M |
|
|
HELI
438
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
| $17.9M | 0.02% |
70,562
-20,093
| -22% | -$4.34M |
|
|
ORBC
439
DELISTED
ORBCOMM, Inc.
ORBC
| $17.5M | 0.02% |
2,656,511
-2,194
| -0.1% | -$14K |
|
|
HMHC
440
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $16.9M | 0.02% |
882,805
+18,063
| +2% | +$350K |
|
|
PKY
441
DELISTED
Parkway, Inc.
PKY
| $16.7M | 0.02% |
808,248
+352,170
| +77% | +$6.84M |
|
|
RAX
442
DELISTED
Rackspace Hosting Inc
RAX
| $16.6M | 0.02% |
493,319
-3,355,492
| -87% | -$111M |
|
|
WBMD
443
DELISTED
WebMD Health Corp.
WBMD
| $16.5M | 0.02% |
342,365
+10,927
| +3% | +$477K |
|
444
CALL
Bausch Health
BHC
$1.7B
| $16.4M | 0.02% |
+130,000
| New | +$16.6M |
|
|
AGTC
445
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $16.4M | 0.02% |
+709,007
| New | +$12.5M |
|
|
TBI
446
Trueblue
TBI
$239M
| $16.3M | 0.02% |
591,258
+255,942
| +76% | +$7.01M |
|
447
DNOW Inc
DNOW
$2.59B
| $15.8M | 0.01% |
+436,094
| New | +$15M |
|
|
FEIC
448
DELISTED
FEI COMPANY
FEIC
| $15.8M | 0.01% |
173,717
+5,808
| +3% | +$511K |
|
449
IMAX
IMAX
$2.43B
| $15.4M | 0.01% |
541,709
-856,380
| -61% | -$22.9M |
|
|
DATA
450
DELISTED
Tableau Software, Inc.
DATA
| $15.4M | 0.01% |
215,951
-1,406,890
| -87% | -$88.2M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.